The dividend-growth based test of return predictability, proposed by Cochrane [2008 , Review of Financial Studies 21, 1533-1575, is similar to a likelihood-based test of the standard return-predictability model, treating the autoregressive parameter of the dividend-price ratio as known. In comparison to standard OLS-based inference, both tests achieve power gains from a strong use of the exact value postulated for the autoregressive parameter. When compared to the likelihood-based test, there are no power advantages for the dividend-growth based test. In common implementations, with the autoregressive parameter set equal to the corresponding OLS estimate, Cochrane's test also suffers from severe size distortions.
1
In this paper, we show that Cochrane's dividend-growth based test is very similar to a test based on the full information maximum likelihood (ML) estimator for the standard return and dividend-price ratio system, with the AR parameter of the dividend-price ratio treated as known. Cochrane's test can thus be viewed as an economically motivated (approximate) derivation of the ML estimator in the case of a known AR parameter.
This finding explains why the dividend-growth based test, as implicitly formulated by Cochrane, appears more powerful than the return-based test using the simple OLS estimator. However, if one were to use the same assumptions when formulating the return-based test, one could use an ML procedure that (asymptotically) dominates the dividend-growth based test. That is, if one compares testing approaches based on the same information set, or the same set of assumptions-treating the AR parameter as known and equal to 1 Cochrane's proposed modelling framework and testing approach has received great interest in the profession, and there is now a host of papers that evaluates both return predictability as well as dividendgrowth predictability. Papers explicitly using Cochrane's (2008) approach to test for return predictability include Chen (2009) ; Engsted and Pedersen (2010) ; Golez and Koudijs (2018) . Related works that consider both return and dividend-growth predictability include, among others, Lettau and Ludvigson (2005) ; Binsbergen and Koijen (2010) ; Lacerda and Santa-Clara (2010) ; Lettau and Ludvigson (2010) ; Chen et al. (2012) ; Kelly and Pruitt (2013) ; Golez (2014) ; Bollerslev et al. (2015) ; Maio and Santa-Clara (2015) ; Detzel and Strauss (2016) . Koijen and Van Nieuwerburgh (2011) provides a review on return and dividend-growth predictability. some given value-there are no apparent gains from using the dividend-growth regression in testing for return predictability.
2
The ML procedure is extremely sensitive to the specific value used for the AR parameter of the dividend-price ratio, and by implication so is Cochrane's procedure. Specifically, the choice to treat the OLS estimate of the AR parameter as the "true" value, which appears to have been adopted in subsequent empirical studies (e.g., Chen, 2009; Engsted and Pedersen, 2010; Golez and Koudijs, 2018) , leads to severe size distortions. A test with a nominal size of five percent is shown to have actual rejection rates in excess of 20 percent under the null hypothesis. On the other hand, if the value of the AR parameter is set high enough, such that it is greater than or equal to the true parameter value in the data, the size of the resulting test can be controlled. For instance, under an assumption that the dividend-price ratio is stationary, setting the AR parameter equal to unity would ensure that it is greater than the true parameter value in the data. In this case, Cochrane's test becomes similar to the conservative sup-bound test developed in Lewellen (2004) and analyzed further in Campbell and Yogo (2006) .
To form some intuition for our results, note that Cochrane's predictive model is made up of three regressions. The regression equations are linked together by the Campbell and Shiller (1988) present value identity, which implies an exact relationship among the slope coefficients as well as the error terms in the three regressions. Thus, any one of the three equations is redundant in the model formulation and the standard bi-variate predictive system, consisting of a predictive regression for returns and an AR process for the dividend-price ratio, must contain exactly the same information as the tri-variate system.
Our results essentially confirm this basic intuition: Adding a fully redundant equation to a regression system should not lead to any statistical gains. From the perspective of empirical research, our findings imply that if one is interested in testing for return predictability, there is no extra information available in the dividend-growth equation, and equally or more powerful tests can be formulated from the standard predictive regression setup.
An empirical application to aggregate U.S. stock returns illustrates our main theoretical results. Specifically, we show that the dividend-growth based test provides very similar results to an ML-based test, and that both tests depend strongly upon the assumption on the maximum feasible value for the AR parameter in the dividend-price ratio. If one is not willing to impose any stronger assumption than stationarity of the dividend-price ratio, both tests fail to reject the null hypothesis of no return predictability at the five percent significance level. On the other hand, if one is willing to assume that the AR parameter in the dividend-price ratio is below about 0.97 in annual data, the evidence would point in favor of return predictability. Seemingly small changes in the assumptions on the AR parameter can thus lead to rather drastic changes in inference.
Testing return predictability 2.1 Model formulation
Our predictive model is identical to the one used by Cochrane (2008) . Let r t denote the log-returns from period t−1 to t, d t the time t log-dividends, and d t −p t the corresponding log dividend-price ratio. The joint model of return and dividend-growth predictability is formulated as the following restricted first-order VAR system,
d t − p t = α dp + φ (d t−1 − p t−1 ) + dp t .
holds,
The identity is obtained through a log-linearization of returns around the long-run mean of the dividend-price ratio, denoted by ρ and empirically defined as
where d − p is the average dividend-price ratio. The parameter ρ is subsequently treated as a fixed and "known" quantity. In the CRSP data used by Cochrane, ρ = 0.9638, and this is the value that we use throughout this study as well.
The present value identity in equation (1) implies the following restrictions on the coefficients and error terms in the predictive equations (E1)-(E3),
The restrictions in (R1) and (R2) imply that any one of the three model equations is redundant, and an equivalent model formulation would be retained by dropping any one of the equations (E1)-(E3).
restriction (R2), the covariance matrix Σ can be written as
σ 11 + ρσ 13 σ 11 + ρ 2 σ 33 + 2ρσ 13 σ 13 + ρσ 33
It is easily seen that Σ is not full rank, reflecting the redundancy in the equation system (E1)-(E3). Cochrane's (2008) key idea is that the absence of return predictability must imply the presence of dividend-growth predictability. That is, the coefficient restriction (R1) implies that if β r = 0,
Standard OLS-based inference
provided ρφ < 1. Thus, under the assumption of φ < 1 (or at a minimum ρφ < 1), it follows that β r = 0 ⇒ β d = − (1 − ρφ) = 0 and β d = 0 ⇒ β r = (1 − ρφ) = 0. Cochrane therefore suggests that instead of testing just the usual simple null, β r = 0, one should also test whether β d = − (1 − ρφ). Thus, the "joint" null hypothesis can be formulated as H 0 : β r = 0 and
Under the maintained model specification, the coefficient restriction
is exact and the restriction also applies to the estimated values (see Appendix A), such (5) viz-á-viz the standard simple null of β r = 0, and no power gains can therefore be achieved through such an approach.
Cochrane's simulation approach
In contrast, Cochrane (2008) proposes a simulation-based approach-from which finitesample distributions of the estimators are obtained-and reports substantially stronger evidence of return predictability when considering a test based on β d rather than β r . The simulations are intended to replicate the estimated model as closely as possible, while imposing the null of no return predictability.
Specifically, the simulated model is specified as follows. The AR parameter φ is set equal to the OLS estimate from the data being used (below, we also discuss alternatives to this parameterization). Given this value of φ, β d is set such that β r = β d + (1 − ρφ) = 0, thus imposing the null of no return predictability. That is,
parameter ρ is set to 0.9638 and the covariance matrix Σ is also set equal to the empirical estimate from the data.
Samples from this model are simulated, and β r and β d are estimated in each of these samples. In particular, equations (E2) and (E3) 
and
are determined based on the empirical distributions ofβ is concluded that the test based on β d is more powerful.
5
Why are the two p-values, p r and p d different? According to the discussion in the previous sub-section, one would expect the tests of β r and β d to be identical. Consider first the case outlined above, where the value of φ used to simulate the dividend-price ratio process is set to φ Data ≡φ Data LS . This specification is the one that seems to have been adopted in subsequent empirical studies (Engsted and Pedersen, 2010; Golez and Koudijs, 2018) , although Cochrane also considers other scenarios that we discuss further 4 Cochrane also considers the empirical distribution of the t-ratiosβ 
The subsequent literature seems to have primarily adopted the tests based directly on the coefficients (e.g., Golez and Koudijs, 2018) , and we similarly focus on these in our analysis. In non-reported Monte Carlo simulations, we find size results for the dividend-growth t-ratio test that are similar to those we document for the coefficient test in Section 3.2 below.
5 The word "power" is used here in a somewhat imprecise sense. Formally, power is defined as the probability of rejecting the null under a given alternative. In Cochrane's simulations, the rejection probabilities are all obtained under the null and are therefore not, in the true sense, a measure of power.
below. To see the implications of this formulation of the simulated model, write
where the first step uses the restriction on the coefficients from the data and the second step simply adds and subtracts ρφ i,sim LS . 6 Using this expression together with the restriction on the estimated coefficients in the simulations (equation (7)), it follows that
How does this simulation-based testing approach differ from the standard OLS inference discussed in the previous sub-section, where the β r -and β d -based tests of return predictability were shown to be identical? The key difference stems from the fact that if one wishes to use the estimate of β d to test a null of β r = 0, the relevant null hypothesis for 
which goes some way towards explaining the results in Cochrane (2008) . In fact, one can get a stronger result. The full information ML estimator of β r with a known φ (see Campbell and Yogo, 2006 ) is given bŷ
In Cochrane's data, σ 13 /σ 33 ≈ −0.9 andβ r,M L ≈β r,LS − 0.9 φ −φ LS . With ρ ≈ 0.96, it follows that , equations (12) and (14) thus give
The test based onβ d,LS in this setup of Cochrane's simulation-based approach therefore turns out to be very similar to a test using the ML estimator of β r , when φ is treated as fixed and known and equal to the OLS estimate in the data. 
Altering the value of φ in the simulations

Is the similarity with ML coincidental?
The near-equivalence of the dividend-growth based test and the ML-based test is seemingly somewhat accidental, and depends on the specific values of σ 13 and σ 33 . Should one in general expect the two procedures to be close? If σ 13 /σ 33 = −ρ, the approximate equality in equation (15) is exact. By the restrictions in the covariance matrix Σ (equation (3)), σ 13 /σ 33 = −ρ is equivalent to σ 23 = 0. Therefore, the near-equivalence of the tests is a result of the near-zero correlation between the dividend-growth and dividend-price ratio innovations observed in the data used by Cochrane (2008) , which cover the U.S. market from 1927 to 2004.
However, σ 23 ≈ 0 does not seem to be a universal fact. The empirical literature has documented a relatively strong correlation (ranging from 0.3 to 0.5) between the dividend-growth and dividend-price ratio innovations in both earlier U.S. data (Chen, 2009 ) as well as in international data (Engsted and Pedersen, 2010) . In these contexts, σ 23 is significantly different from zero, and the dividend-growth based test may differ substantially from the ML-based test.
3 Size and power of the test
Lessons from the ML estimator
The dividend-growth based test was shown to be similar to an ML-based test, where the value of the AR parameter φ specified in the simulation design is treated as the "true"
AR parameter in the ML estimator. Cochrane's dividend-growth based test therefore (approximately) inherits the properties of the ML procedure, for a given specification of the AR parameter.
In case the AR parameter in the simulation design is set to the OLS estimate from the data, the result is a test that is severely over-sized. We illustrate this below by reporting actual rejection rates from a Monte Carlo simulation, under the null of no return predictability. However, the general idea can quite easily be understood by considering the properties of the ML estimator. As remarked above, the ML estimator usingφ LS instead of the true value φ, reduces to the OLS estimator. However, if one now proceeds as if φ LS was indeed the true known value for φ, the (asymptotic) variance of the estimator would erroneously be calculated as (see Appendix A)
where δ 13 = σ 13 √ σ 11 σ 33 is the correlation between the return and the dividend-price ratio innovations. Sinceβ r,M L φ LS =β r,LS , the variance of the ML estimator would therefore be severely under-estimated for large absolute values of δ 13 (in Cochrane's data,
Resulting test statistics based on this (erroneous) result would be over-sized.
7
In general, one never has full knowledge of φ, but one might be willing to impose some upper limit on the range of possible values for φ. Most prominently, one might assume that the dividend-price ratio is a stationary process, such that φ < 1. More generally, suppose one imposes the assumption that φ ≤ φ M ax . In that case, provided σ 13 < 0, one can form a "conservative" (downward biased) estimator of β r ,
This is essentially the approach taken by Lewellen (2004) , although his motivation comes from the finite sample bias result forβ r,LS , derived in Stambaugh (1999) . Campbell and Yogo (2006) also discuss this type of conservative estimator and associated test statistics. Under the assumption that φ ≤ φ M ax , and provided σ 13 < 0, tests based on the resulting estimator are conservative (i.e., under-sized). 
Monte Carlo simulations
The above results are for the actual ML procedure. Given the close similarity between the ML-based test and Cochrane's dividend-growth based test, similar results should also apply to the latter. To verify this, we perform a Monte Carlo simulation where the actual rejection rates under the null of no return predictability are obtained. To be clear, Cochrane's testing procedure is in itself a simulation-based procedure, and here we evaluate the finite sample properties of that procedure in a controlled Monte Carlo experiment. The details of the Monte Carlo simulation are given in Appendix C, but the 7 The OLS estimator is also biased, which further invalidates inference. 8 A conservative implementation is not the only approach to making ML-based inference feasible (i.e., dealing with the fact that the true value of φ is unknown). For instance, Campbell and Yogo (2006) use a bonferroni method to obtain a feasible version of ML-based inference. Analogous implementations of the dividend-growth based test might also be considered, but they add little to the principal discussion regarding the relationship between the ML and dividend-growth based tests. basic setup is described below.
The dividend-growth and dividend-price ratio equations ((E2) and (E3)) are simulated, and the return equation (E1) is inferred from the present-value identity in equation (1).
The null hypothesis β r = 0 is imposed and for a given value for φ, which varies between 0.9 and 0.995, the dividend-growth coefficient β d is implicitly determined by the parameter restriction in equation (R1). The innovations, d t and dp t , are drawn from an iid normal distribution with variances and covariances set equal to the empirical estimates presented in Table 2 in Cochrane (2008) . Intercepts are fitted in all regressions, although these are not commented on below. The sample size in each simulation draw is set to T = 78, the size of Cochrane's original sample. As noted earlier, in the U.S. CRSP data set used by Cochrane, the parameter σ 23 is close to zero and the approximation ρ ≈ −σ 13 /σ 33 therefore holds well (specifically, σ 13 /σ 33 ≈ −0.9 and ρ ≈ 0.96). All simulation results are based on 10,000 repetitions.
We fix the nominal size of Cochrane's test procedure to five percent in a one-sided test against a positive alternative. That is, in each round of the simulations, we reject the null hypothesis of no return predictability for p-values less than or equal to 0.05.
As a comparison to Cochrane's test, we also calculate rejection rates for the ML-based test described in Campbell and Yogo (2006) , which takes the shape of an adjusted ttest (referred to as the Q-test in Campbell and Yogo's notation). For this test, the empirical rejection frequencies are calculated using standard critical values (i.e., reject for test statistics greater than 1.65).
The results from the Monte Carlo simulations are reported in Figure 1 , with the size of the tests plotted as functions of the true parameter value φ in the data generating process.
The dividend-growth based test, using the least squares estimate of φ as the "true" AR parameter, performs very poorly in terms of size. This is true for any underlying AR parameter φ, with rejections rates always in excess of 20 percent for a nominal-sized 5 percent test. The ML-based test implemented in an analogous manner-using the least squares estimate of φ as the "true" AR parameter-suffer from even larger size distortions than the dividend-growth based test, as also illustrated in Figure 1 . This is to be expected, since the ML-based test makes even stronger use of the value for the AR parameter. Figure 1 also presents results for the conservative ML-based test, using equation (17), and the dividend-growth based test performed in an analogous conservative way, where the upper bound for the autoregressive parameter is set to φ M ax = 0.995. In this conservative implementation, both tests exhibit rejection rates that are typically well below the nominal five percent significance level. As the true parameter φ gets closer to the specified upper bound φ M ax , the rejection rates approach five percent.
[Insert Figure 1 here]
Power
Given the large size distortions of the dividend-growth based test that uses the OLS estimate of φ as the "true" AR parameter, there is little use in analyzing the power properties of this specific implementation of Cochrane's dividend-growth based test. The conservative test maintains size well. However, as argued above, this test is similar to Lewellen's (2004) test and Yogo's (2006) sup-bound test. Based on their studies, it is therefore clear that power gains can be achieved by using the dividend-growth equation, but only viz-á-viz standard OLS tests, not against ML-based tests that also use information on the AR parameter. The ML-based test is asymptotically the most powerful (see Campbell and Yogo, 2006) , and the dividend-growth based test can therefore at best (asymptotically) achieve the power of the ML-based test. 9 Strictly speaking, the optimality properties of the ML-based test refers to the case when the AR parameter is fully known. In a conservative formulation of the tests, power comparisons are difficult since, by definition, the tests are not correctly sized in general. In non-reported simulations, we show that under the parameter estimates in Cochrane's study, the power of the ML and dividend-growth based tests are very close in finite samples, both in a conservative implementation and in an implementation where one makes use of the true value of the AR parameter (which is possible in a Monte Carlo exercise).
Our focus is on Cochrane's dividend-growth based test, and we compare it to the ML-based test. Specifically, we estimate equations (E1) As is seen, if one is willing to assume that φ ≤ 0.97, one starts to find significant results.
[Insert Figure 2 here] Figure 2 also clearly illustrates how the empirical results can be viewed as conditional on one's beliefs regarding the autocorrelation in the dividend-price ratio. If one is willing to make stronger assumptions than merely assuming that the dividend-price ratio is stationary, more significant results are obtained. It is worth pointing out that the OLS estimate of φ is equal to 0.94, and using this value as the "true" AR value in the test procedures would thus have led to a strong rejection of the null hypothesis.
Conclusion
We provide a detailed analysis of the properties of the dividend-growth based test of return predictability in Cochrane (2008) . We show that Cochrane's test is similar to a full-information maximum likelihood test, using an explicit assumption on the degree of persistence in the predictor variable. Using this assumption gives both Cochrane's test and the ML-based test additional power over the standard OLS-based test. Cochrane's test can be viewed as an economically motivated proxy for the statistically motivated efficient ML method, and as such Cochrane's test does not add power over and above the previously existing ML-based test. Importantly, we also show that unless one specifically imposes a conservative approach to the formulation of Cochrane's procedure, the test will tend to over reject the null hypothesis of no return predictability. Notes: The graph shows the p-values of tests of return predictability. The p-values are plotted as functions of the value specified for the upper bound, φ M ax , on the AR parameter. The dashed line represents the dividend-growth based test, and the solid line represents the ML-based test (using critical values from the standard normal distribution). Both tests specify that the value for the autoregressive parameter is set to the corresponding value for φ M ax .
A Properties of the OLS and ML estimators
For ease of notation, define x t = d t − p t , and let X −1 denote the vector of stacked lagged observations for x t . Similarly, denote r as the vector of observations on returns, and let r , d , and dp , denote the stacked innovations. We treat the model without intercepts, but the results generalize immediately to regressions with fitted intercepts by replacing all variables by their demeaned versions.
The OLS estimator of β = (β r , β d , φ) is now equal tô
Using β r = β d + (1 − ρφ) and r = d − ρ dp ,
If φ < 1 and t is an iid or martingale difference sequence, it follows straightforwardly from classical asymptotic results that as the sample size T → ∞,
where Σ is given in (3), and V ar x 
For a given set of parameter values, the procedure is summarized by the below steps. For a simulation with 10,000 repetitions, steps 1-4 are repeated 10,000 times.
1. Simulate a single sample of size T = 78 of the system in equations (E1) (1) and (2). Classify as rejection/non-rejection depending on whether the respective p-value is less or greater than 0.05.
The above steps refer to the implementation of Cochrane's procedure where the parametrization in step (3) uses the OLS estimate of φ obtained in step (2). We also consider a conservative test where the value of φ used to parametrize the simulated system in step (3) is set to φ M ax = 0.995 and the value of β d is adjusted accordingly to ensure that the null of no return predictability is imposed (i.e., β d = − 1 − ρφ M ax ).
